Phase I clinical trial of fludarabine phosphate (F-ara-AMP)
- 1 October 1985
- journal article
- research article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 15 (3) , 233-235
- https://doi.org/10.1007/bf00263892
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- PHASE-I CLINICAL INVESTIGATION OF 9-BETA-D-ARABINOFURANOSYL-2-FLUOROADENINE 5'-MONOPHOSPHATE (NSC 312887), A NEW PURINE ANTIMETABOLITE1984
- Has the well gone dry? The First Cain Memorial Award Lecture.1982
- METABOLISM AND CHEMOTHERAPEUTIC ACTIVITY OF 9-BETA-D-ARABINOFURANOSYL-2-FLUOROADENINE AGAINST MURINE LEUKEMIA-L1210 AND EVIDENCE FOR ITS PHOSPHORYLATION BY DEOXYCYTIDINE KINASE1980
- Biologic activity of 9-β-d-arabinofuranosyl-2-fluoroadenine, a metabolically stable analog of 9-β-d-arabinofuranosyladenineBiochemical Pharmacology, 1977
- ENHANCEMENT OF 9-BETA-D-ARABINOFURANOSYLADENINE CYTOTOXICITY TO MOUSE LEUKEMIA-L1210 INVITRO BY 2'-DEOXYCOFORMYCIN1976
- ENHANCEMENT OF ANTITUMOR ACTIVITY OF ARABINOFURANOSYLADENINE BY 2'-DEOXYCOFORMYCIN1976
- Alterations in enzyme activity in tumors and the implications for chemotherapyAdvances in Enzyme Regulation, 1970
- The Antiviral Activity of 9-β-D-Arabinofuranosyladenine (ARA-A)Chemotherapy, 1968
- METABOLIC EFFECTS OF 9-D-ARABINOSYLPURINES IN ASCITES TUMOR CELLS1964